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ReviewGenetic and Functional Relationships
between MHC and NK Receptor Genes
the human genome, notably at the central class III re-
gion, where there is over one gene per 12 kbp. It




to date, the class I and class II molecules. Of the ex-University of Cambridge
pressed loci in the MHC, roughly 40% are associatedTennis Court Road
with the immune system. Some of the main immuneCambridge CB2 1QP
system genes are shown in Figure 2. They include theUnited Kingdom
classical class I, HLA-A, -B, and -C, nonclassical
HLA-E, -F, and -G, as well as “postmodern” MICA and
MICB genes (MHC class I chain-related genes). ThereHLA class I and NK receptors are encoded within
are also nonexpressed pseudogenes representing alldense clusters of immune loci. The MHC, at 6p21.3,
three groups of sequence. The products of classicaland the complex containing the KIR loci, at 19q13.4,
polymorphic class I genes, HLA-A, B, and C, interactboth feature variation in the number of genes, as well
with T cell receptor (TCR) molecules as well as with theas sequence polymorphism. In addition to T cell recep-
products of the killer immunoglobulin-like receptor (KIR)tors, several variable class I-related molecules interact
genes expressed on natural killer cells and some T cells.with polymorphic NK receptors. Some of the lectin-
The KIR interaction sites on class I molecules corre-related NK receptor genes, at 12p13.1, also have li-
spond significantly with known dimorphisms in HLA-Bgands belonging to the extended class I family. The
(Bw4 and Bw6) (HLA-B loci carry “public” epitopesexpanding clusters of class I-related sequences and
which are dimorphisms of amino acids 77–83, dividing
their receptors, some of which evolved recently, reveal
HLA-B sequences into Bw4 and Bw6) and HLA-C (group
further complexity in immune recognition of disease.
1 and group 2 [HLA-C loci are dimorphic for residues
77–80. In general, those with residues N77 and
K80(Cw02, 04, 05, 06 . . .) interact with KIR2DL1, while
The MHC (major histocompatibility complex) and the those with residues S77 and N80(Cw01, 03, 07 . . .)
two sets of genes for NK (natural killer) receptors, the interact with KIR2DL2/3]). HLA-E, on the other hand,
NKC (NK complex of lectin-related genes on chromo- interacts with products belonging to the lectin-like set
some 12p13.1) and the LRC (leukocyte receptor com- of NK receptors in the natural killer complex (NKC). Ex-
plex of immunoglobulin [Ig]-related genes on chromo- pression of the molecule depends on the presence of
some 19q13.4), are large, dense clusters of immune loci. leader sequences from classical class I molecules,
These complexes have some similar features, such as which are needed for HLA-E to reach the cell surface,
where it then interacts with NKG2/CD94 ligand (Braudthe high levels of polymorphism, which may be main-
et al., 1998). In mice, the Qa1 molecule performs a similartained by resistance to infection. Diverse interactions
function to HLA-E, interacting with the evolutionarilyare emerging between the some of the main products
conserved CD94/NKG2 heterodimer, although the twoof MHC and NK clusters, class I molecules and NK re-
class I genes may not be direct orthologs. The functionceptors, respectively (Figure 1). These sets of polymor-
of HLA-F is not known, but it is capable of binding tophic cell surface molecules provide alternative ways of
ILT2 and ILT4 receptors of the Ig superfamily, relatedrecognizing disease and influencing immune responses.
to and mapping alongside the KIR genes (Lepin et al.,The innate immune system, to which NK cells belong,
2000). HLA-G is restricted to the placenta, where it ishas been overshadowed by adaptive immunity, with its
thought to help protect the fetus from rejection by therearranging receptors. The emerging genetic and func-
immune system of the mother (King et al., 2000).tional relationships between the MHC and NK genes
The MIC genes are distant relatives of MHC class Iand their products help to provide a more balanced view
molecules, expressed on intestinal mucosa and on otherof immune recognition. The growing numbers of NK-
cells in response to stress (Bahram et al., 1994). Theserelated receptors and their class I-like partners reveal
genes contain heat shock elements in their promoters.sophisticated recognition systems in which the adaptive
They do not appear to function in presentation of patho-immune system is modulated in novel ways. These inter-
gen-derived peptides to T cells with  TCRs but areactions have implications for understanding susceptibil-
broadly recognized by intraepithelial T cells with ity to infection as well as autoimmunity and cancer.
TCRs. They can also act as costimulatory molecules for
CD8 T cells after induction of expression by viruses
MHC Genes such as CMV (Groh et al., 2001). MICA and MICB are both
The human MHC covers 4 Mbp of DNA on chromo- polymorphic, with an unusual distribution of a number of
some 6p21.3 and contains over 220 identified loci (MHC variant amino acids in their extracellular 1, 2, and 3
Sequencing Consortium, 1999). It has been divided into domains. MIC molecules are neither associated with
three regions: class II (centromeric), class III, and class 2 microglobulin nor bound peptide, and only a small
I (telomeric) with extended class I and class II regions on remnant of a groove remains. Null alleles have been
either side. This is one of the most gene-dense regions of recorded, including haplotypes with no functional MICA
or MICB expression, and mice do not appear to have
MIC genes. MIC proteins interact with a common recep-1 Correspondence: jt233@mole.bio.cam.ac.uk
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Figure 1. Interactions of the Products of Some MHC Class I-Related Genes with Receptors Encoded in the NKC and the LRC
Some of the main sets of genes in the NKC, MHC, and LRC complexes are shown at their approximate chromosomal locations. Known
receptor:ligand interactions are depicted by dotted lines.
tor, comprising NKG2D homodimers, associated with as BTN and BTL, related to the milk protein butyrophilin,
are located in the class II-III border as well as the ex-the adaptor DAP10 (Wu et al., 1999). The NKG2D genes
are located in the NKC on chromosome 12. A MICA tended class I region. The encoded proteins are distantly
related to the expanding family of coreceptor moleculescrystal structure has been obtained as well as a complex
of MICA with NKG2D (Li et al., 2001). Recently, other exemplified by B7.1 and B7.2 that are revealing increas-
ing complexity in costimulatory patterns regulating Tsets of sequences weakly related to class I have been
found to interact with NKG2D. The human ULBP gene cell functions (Coyle and Gutierrez-Ramos, 2001).
MHC Evolution Is Restlessproducts, encoded on chromosome 6q24 (Cosman et
al., 2001), and mouse RAEs (mouse chromosome 10- A good idea is worth imitating. Dot-matrix analysis re-
veals that both class I and class II genes, while main-syntenic to human 6q) (Yokoyama, 2000), may also indi-
cate stress. These molecules resemble the membrane- taining the same basic structure, have undergone re-
peated duplication and loss, maintaining a handful ofdistal parts of HLA class I molecules, the 1 and 2
domains, attached to the cell surface by GPI linkage favored genes in most species, by a continuous “birth-
and-death” process (Shiina et al., 1999). As novel gene(Cosman et al., 2001).
Like class I, class II genes can be divided into classical family members emerged, they have diverged, some
have survived, and others have been lost. Interspersed(HLA-DP, -DQ, and -DR) and nonclassical (HLA-DM
and -DO). All class II molecules are heterodimers, en- within these variable regions are several islands of
unique sequence (e.g., LMP/TAP and RING3) which didcoded by pairs of loci. In all cases except HLA-DO, the
A and B chain genes are adjacent in the genome. HLA- not obviously originate by cis-duplication. The expan-
sions and contractions of sequences have apparentlyDM and -DO do not function directly as presenting mole-
cules, and they do not have peptide binding grooves. taken place against a background of framework loci
that are invariant in number and conserved in differentAt steady state, these molecules are expressed mainly
in MIIC vesicles, where they aid in peptide loading onto species (Amadou, 1999). The class I region has been
subjected to the most interspecies duplication events,classical class II. Another set of MHC-encoded genes
plays a major role in loading peptides onto class I, and haplotypes can differ markedly in the number of
loci (Pichon et al., 1996). Certain species of mice arenamely TAP1/TAP2, LMP2/LMP7, and TAPBP, encoding
the TAPASIN molecule (Lehner and Trowsdale, 1998). estimated to contain hundreds of class I sequences,
most of which have become pseudogenes (Delarbre etOther immune system loci in the complex include cell
surface molecules, such as an activating receptor al., 1992). One mechanism proposed to explain the gen-
eration of the reiterated duplications involves captureNKp30(1C7) on NK cells, IgSF molecules such as MOG,
complement components C2, C4, and factor B, inflam- by retroelements such as retroviruses (Dawkins et al.,
1999), but whether the MHC contains special featuresmatory mediators such as TNF, and three HSP70 loci.
The organization of these genes is similar in man and that enable frequent duplication is not known.
As well as being polygenic, class I and class II genesmouse (Allcock et al., 2000; MHC Sequencing Consor-
tium, 1999). Some families of Ig superfamily genes, such are polymorphic. Sequence variation is not homoge-
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Figure 2. Some of the Main Immune Genes in the MHC
Classical class II genes are purple and nonclassical are pink. Classical class I are dark blue, nonclassical are blue, and others are pale blue.
neous throughout the 4 Mbp MHC region. In the non- after separation from the jawless fish. The adaptive im-
mune system probably came to prominence only in spe-coding sequences, variation increases dramatically by
5- to 50-fold flanking the most polymorphic gene loci cies that arose subsequent to the development of jaws.
Since genome duplication is a feasible precursor to de-(Horton et al., 1998), which may be explained by hitchhik-
ing along with the expressed, polymorphic class I and velopment of a novel network of interacting molecules,
it has been speculated that tetraploidisation of the earlyclass II sequences. The most variable loci are HLA-DPB,
DQ, and DRB in class II and HLA-B and C in class I. vertebrate genome might have been one of the factors
enabling the emergence of an adaptive immune system.Variation is mostly localized within exons 2 and 3 for
class I molecules and exon 2 for class II. There is a There is no direct evidence for this, but the recent dis-
covery of the first living tetraploid mammal, the red vis-predominance of nonsynonymous (i.e., protein chang-
ing) substitutions in regions influencing the peptide cacha rat (Gallardo et al., 1999), lends some credence
to the idea, as does the evidence of multiple rounds ofbinding site, consistent with selection. This pattern of
variation is different than that in most other protein- polyploidisation in Xenopus. Certain MHC genes (TUBB,
TNXB, PBX2, NOTCH4, RXRB, and RPS18) are synteniccoding genes, where allelic variation tends to occur
more in noncoding regions. Over their entire length, in invertebrate genomes, such as D. melanogaster and
C. elegans, so the origin of at least part of the MHCclass I/II alleles differ at 2%–7% of their sites, an order
of magnitude greater than the average proportion of predates the emergence of the adaptive immune sys-
tem. Two bony fish have been studied in detail at thedifferences at other human nuclear genes, which is gen-
erally 0.1%. The generation of the unique pattern of genomic level, namely zebrafish and pufferfish. In tele-
ost fish, class I and class II genes are not linked, butpolymorphism in MHC molecules is the result of point
mutations as well as, perhaps more importantly, either classical class I loci are closely associated with the
immune proteasome components LMP2 and LMP7 asconventional or gene conversion-mediated recombina-
tion (Little and Parham, 1999). In addition to sequence well as TAP transporter loci. In some sharks, there is
strong evidence for linkage between class I and classvariation in the peptide binding domain, DRB and C4
genes are variable in number and position in different II, suggesting that the 500Myr association was lost
at a later stage in the teleosts. A survey of a variety ofhaplotypes (Figure 3).
The discovery of regions paralogous to the MHC at more closely related species is consistent with periodic
upheaval of the MHC (Trowsdale, 1995). In some cases,6p21.3 on chromosomes such as 1, 9, and 19 has been
proposed to result from ancient chromosomal duplica- such as humans and mice, there is no obvious orthology
between class I loci. Apparently, rederivation of the rep-tions (see Flajnik and Kasahara, 2001 [this issue of Im-
munity]). This has been disputed based on phylogenetic ertoire of loci took place subsequent to separation be-
tween the ancestors of the two species, some 80 millionanalysis, but it is clear that some related genes, such
as the NOTCH and RING3 families, are found on all four years ago (Parham, 1994).
The chicken MHC provides evidence of linkage of keychromosomes. The list of genes found in two, three, or
four of the locations already exceeds thirty. The se- MHC genes, including class I and II, TAP transporters,
and C4 genes, in a tight cluster described as a “minimalquence comparisons are consistent with duplications
taking place in a common ancestor of jawed vertebrates, essential MHC” (Kaufman et al., 1999). In this species,
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Figure 3. Variation for Presence/Absence of
Genes in Both the MHC and KIR Clusters
A number of different arrangements for HLA-
DRB genes are shown in the top panel and for
KIR loci underneath. The positions of some of
the KIR loci remain to be firmly established,
and the arrangements are hypothetical. Note
how some framework or anchor loci (red) are
found on all haplotypes and others are highly
variable. For the KIRs, the common “A” hap-
lotype is shown on the top line. A useful web-
site for KIR is: http://www.ncbi.nlm.nih.gov/
PROW/guide/679664748_g.htm
classical, polymorphic class I and class II genes are nations have been offered for association of autoim-
mune conditions with antigen-presenting molecules, butfound alongside TAP and TAPBP as well as C4. Many
of the other genes associated with mammalian MHCs the precise mechanism remains obscure. Since there
are so many common class I and class II alleles in theare deleted or moved. Interestingly, LMP genes are ab-
sent. This may relate to the specificity of the peptide human population, there is effectively no wild-type. “Dis-
ease” alleles are part of the normal, unaffected popula-binding site in chicken class I molecules, which, unusu-
ally, accept peptides with negatively charged COOH tion, consistent with the notion that autoimmune condi-
tions are influenced by widespread contributory factors,termini. The DO gene pair is absent, but DM equivalents
are found. Two C-type lectin genes were identified in including non-MHC genes and environmental effects.
No single class I or class II allele alone is necessary orthe chicken MHC which may be related to natural killer
receptor loci. sufficient to cause disease. In one of the most dramatic
models, HLA-B27 and ankylosing spondylitis, 95% ofThe recent draft sequence of the human genome con-
firms the finding that the MHC is one of the most gene- patients express B27, but only 3% of Caucasians with
the allele will develop the condition (Edwards et al.,dense regions. It also coincides with a zone of extremely
high expression, a so-called RIDGE (for region of in- 2000). The association between narcolepsy and HLA-
DQB1*0602 (A systematic nomenclature has been de-creased gene expression) (Caron et al., 2001). It occu-
pies a region on external chromatin loops in interphase vised to accommodate the growing number of new al-
leles, with the unique locus designation followed by annuclei, which may be related to transcriptional activity
(Volpi et al., 2000). As it is so well documented, the MHC asterisk and a four-digit allele identifier. So for example,
HLA-DRB1*0201 refers to the DRB1 locus, allele 2. Theis a useful model for other genome studies. Recombina-
tion hotspots have been identified in the MHC, for exam- 01 refers to a subdivision, a minor variation of the second
allele. A further optional number can be added for synon-ple, in the class II region between HLA-DNA and RING3,
DQB3-DQB1, and TAP1 and TAP2 (Carrington, 1999). ymous nucleotide changes and noncoding allelic varia-
tion. This nomenclature system is in force for all MHCCrossovers have been located in these regions to within
a few hundred bp, and comparison with equivalent hot class I and II loci as well as other MHC genes, such as
TAP and LMP [see http://www.anthonynolan.com/HIG/spots in rodents has identified recombinogenic chi-like
sequences in some of these locations, the significance index.html]) is another example where the sequence is
present in nearly all patients and is a useful diagnosticof which remains to be determined (Jeffreys et al., 2000).
The MHC and Disease Monitoring criterion, but the frequency of the allele in the normal,
unaffected population approaches 25%.The MHC is associated with more diseases than any
other region of the human genome and is linked to most, Complications arise in analysis of the relationship be-
tween MHC markers and infectious diseases (Meyer andif not all, autoimmune conditions (Parham, 1999). Other
nonimmune disease phenotypes have also been linked Thomson, 2001). There is no simple cause and effect
relationship between disease and alleles of class I andwith the region, from common cancers to enigmatic
disorders such as narcolepsy. The highly polymorphic class II. Although infection is touted to be responsible
for maintaining the profound polymorphism, there areclass I and class II loci are the major determinants of
MHC-associated disease, but the strong linkage dis- few good examples of HLA alleles conferring protection
from infection. HLA-B*5301 is associated with resis-equilibrium across the complex makes it difficult to rule
out a contribution from other linked genes, such as those tance to malaria, but only in specific populations. There
is evidence that evolution of the widespread, geneticallyin the class III or extended class I regions. Various expla-
Review
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Figure 4. Interactions between MHC Class I
Molecules and Inhibitory Receptors
Both 2- and 3-domain Ig superfamily and lec-
tin receptors are shown along with chromo-
somal assignments. ITIM motifs are repre-
sented as boxes. The Ig domains in the KIR
family bend back into an elbow shape (Fan
et al., 2001). ILT2/4 have been shown to be
capable of binding the 3 domain of various
class I molecules, such as HLA-A, B, F, and G.
stable Epstein-Barr virus is constrained by HLA class I. If subunits were encoded on different chromosomes,
pairing of the heterodimer could be compromised (Ger-An epitope of nuclear antigen 4 of the virus dominates
the class I response and is presented by HLA-A11. The main et al., 1985). Another example of this is provided
by rat TAP alleles, which can differ by up to 30 aminoepitope is conserved in Caucasian and African popula-
tions, where A11 is relatively infrequent. Strains of the acids. Different allelic products can result in transport of
peptides with either positive or neutral COOH termini,virus from New Guinea, where HLA-A11 is highly preva-
lent, carry a mutation in the epitope that precludes its which are only suitable for particular alleles of class I.
Class I and TAP alleles on single haplotypes are nicelybinding to the class I molecule. Maintenance of so many
MHC alleles may be through heterozygous advantage matched to each other, ensuring transport of peptide
for binding to the appropriate groove. This notion ofor frequency-dependent selection (Parham and Ohta,
1996). Either model is consistent with multiple extant haplotypes with sets of polymorphic loci in counterpoint
may apply to the string of other immune genes in thealleles. Heterozygous advantage of HLA class I in rela-
tion to length of time to AIDS after HIV seropositivity MHC. Immunomodulatory genes, such as TNF, linked
to particular HLA alleles may ensure an optimum levelhas been documented (Carrington et al., 1999). With a
chronic infection such as HIV, where the virus sequence of immune response even with vastly different class I
and II molecules (Gruen and Weissman, 1997). In theis unstable, it is reasonable to propose that heterozy-
gotes have an increased chance of possessing an HLA class II region, there is evidence of a recombination hot
spot between the TAP loci, resulting in linkage equilib-allotype that can present an appropriate pathogen-
derived peptide for T cell recognition. In another study, rium. Perversely, DP and DQ/DR genes, either side of
the TAP loci, are in linkage disequilibrium. This suggestsa single allele, HLA-B*5701, was found to have a protec-
tive effect on virus replication (Migueles et al., 2000). that selection favoring association of the class II loci
counters the breakup of associations caused by recom-Decades of MHC/disease studies have uncovered many
weak but significant associations. Haemochromatosis bination in the intervening region (Meyer and Thomson,
2001).is one of the few major diseases strongly identified by
MHC variation, but it mapped some distance away, at
the HFE locus. Paradoxically, HFE turned out to be re- NK Receptor Genes
The known roles of natural killer (NK) cells include modu-lated to class I, but it does not present to an immune
receptor. The extensive MHC linkage disequilibrium, lation of the immune system by the elaboration of cyto-
kines as well as killing of infected cells. Detection ofwhich confounded identification of HFE for many years,
is also thought to be indicative of selection. targets by NK cells is mediated by two major families
of receptor molecules belonging to the immunoglobulinMHC Teamwork
The clustering of immune genes in the MHC may be superfamily (IgSF) and to the C-type lectin superfamily,
respectively. The ligands for many, but not all, of thesesimply fortuitous, although there could be advantages
in coinheritance of multiple polymorphic loci. Linkage receptors are MHC class I molecules. As summarized
in Figures 4 and 5, the receptors are either activatingcould help to coordinate gene expression and exchange
of sequences by nonhomologous recombination mech- or inhibitory. They quite often occur as pairs, comprising
one of each type, although they are not necessarily im-anisms such as gene conversion. Another putative ad-
vantage to linkage of polymorphic genes is cis-inheri- mediately adjacent in the linkage group. Effector func-
tions are controlled by sequences in the transmembranetance of functionally interacting components. DQA and
DQB subunits, for example, are both highly polymorphic. and cytoplasmic tails (Vely and Vivier, 1997). Inhibitory
Immunity
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variety of different tissues, particularly in the haemo-
poietic lineages. The products of some of these genes,
such as the Ig-like transcripts (ILTs or leukocyte Ig-like
receptors, LIR or CD85; the official HUGO nomenclature
is LILR, see http://www.gene.ucl.ac.uk/nomenclature),
are expressed on an extended range of cell types
(Borges et al., 1997; Colonna et al., 1999).
The NKC on chromosome 12p13 encodes over 15
type II transmembrane C-type lectin-like proteins. As
well as NK cells, some NKC genes are found on a wider
range of haemopoietic cell types. Multiple duplications
must have given rise to this extensive cluster of related
loci, which extends over 1.5 Mbp. There is evidence
for recent duplication, as some of the genes, such as
the NKG2 loci, are over 90% identical. There are obvious
NKC orthologs in different species, such as CD69 and
CD94, as well as species-specific loci (Barten et al.,
2001). For example, three NKRP1 genes have been iden-
tified in mouse and two in rat, whereas humans probably
have only one functional gene. Mice have the NKR-P1A
ortholog as well as the related NKR-P1C gene in addition
to an ITIM-containing inhibitory molecule, NKR-P1B.
The Ly49 family is subject to marked interspecies differ-
ences. The exact number of murine Ly49 genes is not
known, but there could be in the range of 12–15 genes,
whereas there is only one pseudogene in man, LY49L.
There is little sequence available for the mouse NKC,
but once this has been obtained it will be interesting to
account for the size difference of the human NKC (2
Figure 5. Interactions between MHC Class I-Related Molecules and MBp) and the mouse (4 MBp). This difference could
Activating Receptors be mainly due to expansion of the Ly49 gene family
A range of activating receptors are shown along with their chromo- between the NK2GA and Ly49b loci (Barten et al., 2001).
somal positions and class I ligands, where known. TM adapters are Southern blots showed that different inbred mouse
shown next to each receptor molecule, with ITAM motifs repre-
strains exhibit a high degree of variation as well as differ-sented as discs. KIR2DL4 has been proposed to be an activating
ent numbers of Ly49 genes. These data, together withreceptor, but this has not yet been confirmed.
the limited sequence analysis, are consistent with haplo-
typic variation in arrangement of Ly49 genes (Brown et
molecules function via the well-documented immunore-
al., 2000).
ceptor tyrosine-based inhibitory motifs (ITIMs) (Long,
Comparison of chimpanzee and human NKG2 genes
1999). Activating receptors have truncated cytoplasmic reveals recent evolutionary processes. The different
domains lacking ITIMs. They associate with immunore- NKG2 loci, with the exception of NKG2D, are more simi-
ceptor tyrosine-based activation motif (ITAM)-bearing lar within, than between, different species, such as hu-
adaptor molecules (Isakov, 1998), such as the DAP12 mans and mice (Vance et al., 1999). This is consistent
molecule. Association between the transmembrane re- with a rederivation of different loci in individual species
gions of receptor and adaptor neutralizes oppositely by duplication of a single locus. Continuous incarnation
charged residues, such as an aspartate in DAP12 and of genes is characteristic of other key immune loci (Nei
a positively charged residue on the TM region of the et al., 1997), including MHC class I sequences, which
receptor (Campbell and Colonna, 1999). are also nonorthologous between humans and rodents
There Are Two Major Clusters of Genes for NK (Parham, 1994).
Receptors, the NKC and the LRC A locus, Cmv-1, mediating resistance to mouse CMV
Genes for inhibitory receptors are clustered on two chro- mapped to the Ly49 region. B6 mice but not BALB/c
mosomes (Figure 6). The C-type lectin genes, such as are resistant to the virus. Resistance to ectromelia virus
CD94 and NKG2, are grouped in a 2 Mbp region of maps to a similar region which may not be identical
human chromosome 12, the natural killer complex, or to Cmv-1 (Depatie et al., 1997). The two phenotypes,
NKC (Brown et al., 2000). The Ig superfamily genes, on resistance to ectromelia virus-induced necrosis (Rmp1)
the other hand, are clustered in the leukocyte receptor and acute splenic replication of mouse CMV (Cmv-1),
complex (LRC) on human chromosome 19q13.4. Acti- are thought to be both mediated by NK cells. Recent
vating versions of the receptors belonging to the same work points to the Cmv-1 locus as being allelic to Ly49h
molecular superfamilies are interleaved with their inhibi- (Klra8) (Lee et al., 2001) and to the direct involvement
tory counterparts (Moretta et al., 2000). Additional genes of an NK receptor in resistance to viral infection (Brown
encoding activating or inhibitory receptors on NK cells et al., 2001). The proposed mechanism of action of the
have been identified (Parham, 1997), and most of these encoded receptor is interesting. MCMV produces an
also fit into the two extended superfamilies. Sequences MHC class I-like protein, gp144, that binds to inhibitory
receptors on NK cells, blocking activation, which wouldwith varying degrees of relatedness are present on a
Review
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Figure 6. Receptor Genes in the Human NKC and LRC Regions
Only the lectin-related (NKC) and Ig superfamily (LRC) encoding molecules are shown. The maps are not to scale.
be a consequence of downregulation of host class I by Other related molecules encoded centromeric of the
LRC include the sialic-acid binding Ig-like lectins (Sig-the virus. It is suggested that mouse NK cells counter
this strategy by producing a stimulatory receptor, en- lecs [Alternative names for Siglecs include sialoadhesin,
CD169, CD22, CD33, MAG, CD170, and p75/AIRM-1coded by Klra8, which binds ligands specifically ex-
pressed by MCMV-infected cells. This example of a re- (Crocker and Varki, 2001)]), of which there are ten genes
so far (Crocker and Varki, 2001), and the CD66-relatedceptor/ligand arms race may help to explain the
proliferation of other activating NK-related receptors, molecules. The Siglecs are expressed on a range of
haemopoietic cells other than CD4 T cells. They mostfor which, in most cases, ligands remain to be found.
As expected from duplicated genes, the structures likely also form part of the innate immune system re-
sponsible for sensing infection. The CD66 gene familyof the NKC-encoded C-type lectin-like loci are highly
related. Up to two exons encode the 3UTR and cyto- includes the group of molecules commonly known as
CEA, for carcinoembryonic antigen. There are approxi-plasmic tail, and a single exon covers the transmem-
brane region. In each case, three separate exons encode mately 29 CD66 genes, 18 of which are expressed (Ham-
martsrom, 1999). Some 7 CEA genes encode mem-the carbohydrate recognition domain (CRD). The only
major variation is the separate exon for a stalk region brane-spanning cell surface molecules, with 1–4 Ig
domains. Another group of 11 genes encode secretedbetween the TM and the CRD, which several genes do
not have. Interestingly, the stalk is involved in the ligand molecules, belonging to the pregnancy-specific glyco-
protein subgroup. Some CEA molecules possess homo-specificity of Ly49A and -C, as revealed by binding
assays using chimeric molecules (Takei et al., 1997). So and heterotypic cell adhesion properties. Other Ig super-
family genes map to the extended LRC, includingfar, ligands have not been found for proteins without
the neck region. Some C-type lectins interact with car- FCGRT, encoding the class I-related neonatal FcRN, as
well as CD79a and CD155.bohydrate in a calcium-dependent manner, but carbo-
hydrate is not required for CD94/NKG2 interaction with Even further centromeric, at 19q13.1, are two of the
genes for TM adaptor molecules. DAP12 complexesHLA-E.
The LRC cluster of loci on chromosome 19q13.4 con- with activating receptors both within the LRC as well
as the NKC. DAP10/KAP10 associates with the NKC-tains over 25 Ig superfamily genes, consistent with ex-
tensive duplication (Figure 6) (Barten et al., 2001; Wilson encoded NKG2D molecule, the ligand for MICA/B, RAE,
H60, and ULBP (Cosman et al., 2001; Lanier et al., 1998).et al., 2000). Some loci in the LRC, such as NKp46, are
orthologous in humans and mice (Biassoni et al., 1999), The DAP12 and DAP10 genes are arranged tail to tail,
separated by 300 bp. Unlike other adapters, DAP10so primordial genes must have been present before spe-
ciation between man and rodents (80 million years contains a YINM motif in its cytoplasmic tail, the phos-
phorylation of which can result in PI-3 kinase and Grb-2ago). Some of the other genes, such as the PIRs and
the ILTs, are also likely to be orthologs (Kubagawa et association.
Another set of related genes, the SIRPS (signal regula-al., 1999), but KIRs appear to be completely absent
in rodents and may have only developed in primates tory protein), are encoded on chromosome 20. The CD47
molecule (also IAP, for integrin-associated protein) acts(Khakoo et al., 2000). Chicken Ig receptors related to
PIRs and Fc receptors have been identified, consistent as a self-marker on red blood cells, which are cleared
from the bloodstream of mice if they are CD47-ve. CD47with a common origin (Dennis et al., 2000). The collagen
receptor gene, platelet glycoprotein receptor VI (GPVI), on normal red blood cells prevented this elimination by
binding to the inhibitory receptor SIRP (Oldenborg etmaps to the telomeric end of the LRC. This gene is
related to the other loci in the LRC and, like ILT, the al., 2000).
The arrangement of the signal sequence on two exonsprotein product associates with Fc common  chain
(FcR) for signal transduction. is characteristic of the KIRs as well as the related Fc
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receptors. Exon-intron organization is generally con- between the FcR and GPVI loci is closer to the genome
served in the Ig receptor superfamily. KIR loci with only average of 3–5, consistent with the relative age of the loci
two Ig domains seem to have been derived from genes compared to the KIR sequences. Minisatellite-related
with three domains by exon skipping. In some cases, sequences are present in KIR loci. Each minisatellite
the surplus exons have deleterious mutations. These contains multiple copies of imperfect repeats of a 19–20
mutations may help to facilitate elimination of the exon, bp sequence. Each KIR locus contains an invariant num-
since nonsense or missense mutations have been dem- ber of repeat units, from 23 in the 2DL5 gene to 63 in
onstrated to result in skipping of an exon in the BRCA1 2DS4. No allelic variation has been found in these re-
locus (Liu et al., 2001). Inhibitory and activating versions peats so far. G  C-rich minisatellites are associated
of KIR loci are highly similar in sequence, and small with recombination and/or variation (Jeffreys et al.,
alterations in an inhibitory receptor are sufficient to cre- 2000), and the KIR minisatellites may possibly affect
ate a charged residue upstream of a stop codon, making the stochastic regulation of expression in different NK
an activating version capable of recruitment of DAP12 clones (Uhrberg et al., 1997). The KIR2DL4 gene is
and loss of ITIM motifs. flanked by unique sequence, and, as opposed to the
KIR genes are arranged head to tail 2 kbp apart in other KIR loci, the gene is expressed in most NK cells.
a continuous reiterated sequence with just one unique Asimov devised three famous rules of robotics. Ac-
section 14 kbp upstream of the KIR2DL4 locus (Wilson cordingly, in the “missing self hypothesis” (Karre, 1997),
et al., 2000). In line with other data, this arrangement is a similar code of conduct could be devised for NK
also consistent with recent duplication of KIR genes.
clones:
Like MHC class I and class II sequences, NK receptor
1. Express at least one inhibitory receptor for a selfKIR loci are highly polymorphic (Uhrberg et al., 1997;
class I molecule.Valiante et al., 1997). As shown in Figure 3, another
2. Do not change which receptors you express.feature of the MHC, particularly the class II genes, is
3. Inhibition overrides activation.variation for the presence or absence of loci, such as
These rules do not preclude NK clones expressingin the DRB and C4 clusters. And like these loci, KIR loci
receptors for ligands they do not have, which does arise.are variable both in sequence as well as for presence/
It follows that KIR genes are each only expressed on aabsence on different haplotypes (Figure 3). Some KIR
certain fraction of the NK cell population, yet they shareare present on all or most haplotypes. Between these
identity over their upstream promoter regions of overframework sequences the number of KIR genes varies.
91%. The flanking, anchor loci KIR3DL3 and KIR2DL4Gain/loss variation throughout evolution may take place
have more divergent promoter sequences of 89% andby nonreciprocal recombination. The reiteration of KIR
69% identity, respectively. Few physiological transcriptsloci in a head-to-tail arrangement may help to facilitate
of KIR3DL3 have been reported. KIR2DL4 is expressedthis, resulting in multiple haplotypes with different gene
on 100% of NK cell clones. How is control over genearrangements. Most KIR loci also have multiple alleles.
expression exercised to satisfy rule 2? The high degreeThe inhibitory KIR3DS1 and activating KIR3DL1 se-
of sequence homology suggests that KIR genes arequences are apparently alleles at a single locus (Gardi-
likely to be regulated by a stochastic mechanism, possi-ner et al., 2001; Uhrberg et al., 1997; Wilson et al., 2000).
There is no indication so far that regions flanking highly bly involving methylation. The high level of homology of
polymorphic KIR loci also show polarized variation, as KIR promoters does not allow identification of transcrip-
in MHC class I and class II genes (Beck and Trowsdale, tion factors specific for individual KIR expression. The
2000). Marked variation in KIR sequences is, as ex- finding of nonexpressed KIR2DL5 variants suggests that
pected, found in those residues that impact class I struc- a mutation in a putative AML transcription factor site
tures (Gardiner et al., 2001). Variation elsewhere in the may prevent these variants from being expressed
genes may influence expression either through alter- (Vilches et al., 2000). The binding site for AML is con-
ation in the transmembrane region or in the promoter served between all other KIR promoters including
sequences. KIR2DL4. This family of transcription factors regulates
The immunoglobulin-like transcript (ILT, LIR, or LILR) a variety of hematopoietic genes. They can act both as
genes are in two clusters of 6–7 loci, each linked to a positive as well as negative regulators of transcription.
single leukocyte-associated inhibitory receptor (LAIR) Divergent, Convergent, and Coevolution of NK
locus, orientated in opposite directions. In contrast to
Receptors and Ligands
the KIRs, the ILT introns and intergenic regions are not
Although some primate lineages may have functionalhighly homologous, and ILT loci are probably older than
Ly49 genes, a single pseudogene is now left in man.the KIR genes. Comparison with murine PIRs suggests
Similarly, there is no identifiable trace of KIR genes inthat these loci are orthologous in the two species (Blery
mice. The logical conclusion, now generally accepted,et al., 1998). Apart from the single exception of ILT6,
is that mouse Ly49 and human KIR genes are functionalILT loci are present on all haplotypes. Some of the ILT
homologs, although they come from different structuralsequences are highly variable, including ILT5 and ILT8
families. The two sets of genes share some striking(Colonna et al., 1997).
features. As well as recognizing MHC class I, they areThere are 9 AluS sequences and no AluJs in each
both expressed in a clonal fashion on different NK cellsKIR gene, so the AluS/J ratio is extremely high over the
and they are both polymorphic. They use similar mecha-KIR region (cf. the MHC above, where the ratio is 3).
nisms for signal transduction. The existence of genesThis is also consistent with the recent derivation of KIR,
from different superfamilies performing related func-restricted to primates (Rajalingam et al., 2001). The S/J
ratio over ILT sequences as well as over the region tions in different species is an intriguing example of
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inversions on chromosome 19 could have relocated the
CD155 and the class I-like FCGRT gene (encodes FcRN,
which is responsible for transfer of IgG molecules across
the placenta) to 19q13.2 (Du Pasquier, 2000). Inversions
may account for scrambling MHC paralogous genes on
chromosome 1 and for separation of the class I-related
ULBP loci to 6q, near to T complex genes, which are
MHC linked in mice. Another LRC gene, FcAR, is related
to other C2-set Ig superfamily molecules (Dennis et al.,
2000). All of the other Fc receptor loci are on human
chromosome 1. One end of the NKC on chromosome
12 contains a small set of MHC-paralogous loci including
a gene related to TAPBP (Du Pasquier, 2000).
Much of the genomic clustering of NK-receptor-
related genes such as the KIRs has resulted from re-
peated cis-duplication. Duplication of IgSF genes has
obviously been a major factor in shaping the immune
system, colonizing multiple chromosomes. Homotypic
or heterotypic associations of IgSF proteins are com-
mon. Multimerization may have been a factor in the
development of NK receptors, as it could lead to “zip-
pering” of a mixture of inhibitory and activating recep-
tors with MHC class I ligands when an NK cell interacts
Figure 7. Divergent and Convergent Evolution of NK Receptors by with its target (Boyington et al., 2000). Cis-cis associa-
Development of KIR Genes in Human and Ly49 in Mouse tion of inhibitory and activating receptors could be an
The maps are not to scale. attractive evolutionary intermediate on the path to mod-
ulating target recognition. The structures of both KIR
and Ly-49 reveal two different interfaces with class Iconvergent evolution (Figure 7) (Barten et al., 2001). The
molecules, resulting in cocrystals with extensive or-evidence is consistent with the gradual replacement of
dered ligand-receptor oligomerization. If these struc-the functions of Ly49 and the loss of LY49 genes as
tures are recapitulated at the immune synapse, theyKIRs emerged, very recently, in some primates. On the
could facilitate the formation of an extensive bridgingother hand, KIR genes may have never developed in
network. The cooperative effect of this arrangement,rodents, although the syntenic region can be identified.
which has been proposed for coreceptors such asAs shown in Figure 7, the two major groups of receptor
CTLA4/CD28, would be to boost avidity. The precisegenes, the LRC and NKC, are both identifiable as syn-
way in which signals from both inhibitory and activating
tenic clusters. The FcR and gpVI loci effectively tag
NK receptors are integrated is not fully understood, but
one end of the LRC in man and mouse. Many of the
ways could be imagined in which the network could be
genes in both the LRC and NKC complexes have re-
disturbed in this situation by mixtures of activating and
mained in order in the diverse species even though the inhibitory receptors. The signaling components, which
functional, polymorphic NK receptor subsets eventually are common to other systems, call for close integration
polarized to different gene sets. of inhibitory and activating receptors.
Why did KIR genes develop in only a few species, The range of expression patterns, ligands, and func-
one of which considers itself the most advanced? The tions of Ig superfamily molecules along chromosome 19
simplest explanation is that the genes arose subsequent is extensive. So far, all the known ligands for KIRs are
to, and to compensate for, deletion of Ly49. Another class I molecules. The variety of ligands for related mole-
possibility is that KIRs perform novel functions, and their cules such as GPVI, CD66, and NKp46 indicate the ex-
emergence initially provided a key selective advantage. treme versatility of this molecular family, which extends
To explain the rapid evolution of KIR, it has been sug- to hematopoietic receptors such as human growth hor-
gested that they interact with ligands different than the mone receptor, prolactin receptor, and erythropoietin
known class I structures (Rajalingam et al., 2001). receptor (Fan et al., 1997). Cells can become activated
Whether or not this intriguing idea turns out to true, NK when NKp46 binds via sialic acid to flu haemagglutinin,
receptor evolution must be to some extent tied in with taking advantage of an essential structural component
class I ligands, which, as pointed out above, are often of the virus (Mandelboim et al., 2001). The in vivo ligands
unique to each species. for most of the ILTs remain to be found. Some viral
It has been speculated that lectin genes, rearranging proteins, such as UL18 from CMV, bind ILTs, presumably
IgSF genes, and their receptors all emerged from the disrupting host receptor/ligand interaction and poten-
MHC. There are a few scraps of evidence of ancient tially modulating ILT functions in monocytes (Borges et
genetic links, such as the putative NK receptor genes al., 1999).
in the chicken MHC, which could be coevolving with The MHC and LRC both have highly conserved sub-
linked class I alleles (Kaufman et al., 1999). The short sections that consist of multiply duplicated genes, such
arm of human chromosome 19 at 19p13.1-13.3, where as the class I or class II genes in the MHC and the ILT
two lectin-related DC-SIGN genes and the CD23 gene genes in the LRC. Both also feature a segment with
isotypic as well as allotypic diversity. In both complexes,are located, is paralogous with the MHC. Pericentric
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features of the DNA sequence are characteristic of terri- innate and adaptive immunity are truly integrated and
tories with different gene content. In the MHC, GC rich- highly complex (Brown, 2001). They suggest novel initia-
ness demarcates transition to different zones. In the tives for investigating immune regulation, tumor immu-
LRC, the ILT and KIR regions may be distinguished by nosurveillance (Smyth et al., 2001), and autoimunity (Yen
variation in Alu repeat content, in addition to intragenic et al., 2001) based on the existence of two interacting
distance and the presence of KIR-specific minisatellites sets of highly polymorphic loci.
(Wilson et al., 2000). The extreme variation in both re-
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